Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

US Patent 10351589 · Granted Jul 16, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with2022
3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor2021
3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment2021
Steroid compound for use in the treatment of hepatic encephalopathy2019
Methods for treating hypersomnolence2019
Steroid compound for use in the treatment of hepatic encephalopathy2017
Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with2017
Steroids having increased water solubility and resistance against metabolism and2015
Steroids having increased water solubility and resistance against metabolism and2015
Steroids having increased water solubility and resistance against metabolism, an2014
Steroids having increased water solubility and resistance against metabolism, an2014
Steroids having increased water solubility and resistance against metabolism, an2013